Table 1.
Demographic characteristics, and identification of SARS-CoV-2 infection cases
| Overall (n = 49) | BNT162b2 (n = 15) | CoronaVac (n = 34) | Subgroup of CoronaVac (Booster dose of BNT162b2) (n = 23) | |
|---|---|---|---|---|
| Sex | ||||
| Male, n (%) | 13 (26.5%) | 3 (20%) | 10 (29.4%) | 8 (34.8%) |
| Female, n (%) | 36 (73.5%) | 12 (80%) | 24 (70.6%) | 15 (65.2%) |
| Age | ||||
| 15–60 years, n (%) | 48 (98.0%) | 15 (100%) | 33 (97.1%) | 22 (95.7%) |
| Over 60 years, n (%) | 1 (2.0%) | – | 1 (2.9%) | 1 (4.3%) |
| Median (range) | 33 (15–80) | 36 (15–53) | 33 (21–80) | 35 (23–80) |
| SARS-CoV-2 infection cases | ||||
| Participants, n (%) | 3 (6.1%) | – | 3 (8.8%) | 2 (8.7%) |